Latest Australian Securities Exchange News

Cluey Ltd has formally requested voluntary delisting from the ASX, with the exchange agreeing in principle subject to shareholder approval and regulatory conditions. A general meeting is scheduled for 13 August 2026 to vote on the proposal.

Global X Management (AUS) Limited has announced estimated distributions for over 30 ETFs for the period ending 30 June 2026, all eligible for reinvestment via its Distribution Reinvestment Plan (DRP). The announcement outlines key dates for investors to act on their DRP elections and highlights the wide range of income levels across its funds.

SIV Capital has been advised by the ASX of a significant risk that it will fail to meet key listing requirements, prompting the company to explore alternative paths forward.

Cluey Ltd plans to voluntarily delist from the ASX, citing thin trading volumes, undervaluation, and cost savings of around A$500,000 annually. Shareholders will vote on the proposal in August 2026, alongside a small parcel buy-back and the closure of its UK subsidiary Code Camp.

SDI Limited shareholders voted overwhelmingly in favour of a $1.40 per share acquisition scheme by InnoXvest Dental, setting the stage for court approval and delisting.

Cynata Therapeutics (ASX: CYP) has had its trading suspension lifted immediately following the publication of results from its Phase 3 Osteoarthritis and Phase 2 Graft versus Host Disease clinical trials.

The ASX has suspended trading of Canadian Phosphate Limited’s CP8O securities pending compliance with specific listing rules, a move that isolates this security class without affecting the company’s other quoted shares.

Australian Gold and Copper Ltd (ASX: AGC) is set to expand its NSW footprint by acquiring the Junee Gold Project for $5.4 million in shares, supported by a concurrent $5 million placement to accelerate exploration.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

Venus Metals has sold its 1% Youanmi gold royalty to Franco-Nevada for $46 million, triggering plans for $35 million in special dividends and an in-specie distribution of Rox shares to shareholders.

Novo Resources Corp has closed Tranche 2 of its placement, raising approximately C$1.93 million and issuing options to joint lead managers and participants, while Northern Star retains a near 10% stake.